Anchorage Calf Augmentation

Anchorage Calf Augmentation Related Terms:
Anchorage Body Procedures, Anchorage Calf, Anchorage Calf Implant, Anchorage Calf Lift, Anchorage Calf Muscle, Anchorage Calfs, Anchorage Calves, Anchorage Cosmetic Surgery, Anchorage Implants, Anchorage Leg Surgery, Anchorage Plastic Surgery, Anchorage Sura, Calf Augmentation In Anchorage AK Alaska

This procedure offers a solution for those people that have underdeveloped calves or wish to augment them. The idea is to shape and size the calves by surgical insertion of implants. The implants are made of soft silicon and they come in different shapes and sizes. Before the operation your legs will be measured to select a proper implant for your needs. There is an alternative to implants. Calf augmentation can also be performed by liposuction of fat from other body parts and injecting it into the calves. This method is not suitable for people with no extra fat to be removed. Another problem is fat absorption that eventually occurs, sometimes creating not symmetric calves. Men and women can benefit from this procedure. Men usually want to increase the muscle bulk, giving them more masculine look and women wish to get more symmetrical appearance of their legs. This procedure also may help to correct some congenital defects, those include polio, spina bifida and clubfoot, all this conditions may be associated with undeveloped calves.

This procedure can be done with local or general anesthesia, and it usually lasts for an hour. During the operation the patient is laying on their back. A cut is made in the concavity behind the knee, then the skin is gently separated and a space is created. The implant is inserted above the muscles. After one leg is done the doctor performs the same on the other one. After the symmetry is confirmed the surgeon closes the cuts with stitches.

Every operation has its ricks. This one includes bleeding, infection and sometimes implants shrinkage and asymmetry.

After the surgery you may feel some degree of pain. Your doctor`ll subscribe you for painkillers. At the first two days you`ll be asked to raise your legs whenever you are sitting, this to reduce swelling. Afterwards, the bandages are removed and you are encouraged to walk more intensively to train your calve muscles. For about two weeks you`ll fell like you`re calves is been through excessive workout. Swelling and bruising also may appear, they are only temporary and will improve with time. You`ll be able to go back to work after 7-10 days. You`ll get detailed instructions from you`re surgeon regarding the activities you should avoid, for example long walking, weight lifting and running. Usually, most of the patients are able to return to their daily activities after 4-6 weeks.

Planing on having calf augmentation procedure in Anchorage AK?
Here is some General Information about Anchorage AK:

Anchorage Budget
Anchorage International Hostel Downtown, 700 H Street, Phone: +1 (907) 276-3635, Fax: +1 (907) 276-7772, (mailto:information@anchorageinternationalhostel.org), [18]. Office Hours:8am - 12pm, 5pm - 11pm Alaska Standard Time (1 hour earlier than Pacific Standard Time). This hostel is located one block from the downtown transit center(served by all PeopleMover routes except 1) and about seven blocks from the Alaska Railroad Station. Close walking distance to many downtown restaurants, coffee shops, and shopping venues.

(WikiT)...

Anchorage AK calf augmentation - Tip of the day:
What are the Health Benefits of Calf Augmentation?
This cosmetic procedure also may help correct some congenital defects, which include polio, spina bifida and clubfoot, where all such conditions may be associated with undeveloped calves. A lot of patients in Anchorage,AK (Alaska) have opted to undergo such treatment for the following health reasons.

Anchorage AK calf augmentation - News update:

Context Coronary artery bypass graft (CABG) surgery is frequently performed and effective; however, perioperative complications related to ischemia-reperfusion injury, including myocardial infarction (MI), remain common and result in significant morbidity and mortality. MC-1, a naturally occurring pyridoxine metabolite and purinergic receptor antagonist, prevents cellular calcium overload and may reduce ischemia-reperfusion injury. Phase 2 trial data suggest that MC-1 may reduce death or MI in high-risk patients undergoing CABG surgery.

Objective To assess the efficacy and safety of MC-1 administered immediately before and for 30 days after surgery in patients undergoing CABG surgery.

Design, Setting, and Participants The MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery II Trial, a phase 3, multicenter, randomized, double-blind, placebo-controlled trial, with 3023 intermediate- to high-risk patients undergoing CABG surgery with cardiopulmonary bypass enrolled between October 2006 and September 2007 at 130 sites in Canada, the United States, and Germany.

Interventions Patients received either MC-1, 250 mg/d (n = 1519), or matching placebo (n = 1504) immediately before and for 30 days after CABG surgery.

Main Outcome Measures The primary efficacy outcome was cardiovascular death or nonfatal MI, defined as a creatine kinase (CK) MB fraction of at least 100 ng/mL or new Q waves through postoperative day 30.

Results The primary efficacy outcome occurred in 140 of 1510 patients (9.3%) in the MC-1 group and 133 of 1486 patients (9.0%) in the placebo group (risk ratio, 1.04; 95% confidence interval, 0.83-1.30; P = .76). All-cause mortality was higher among patients assigned to MC-1 than placebo at 4 days (1.0% vs 0.3%; P = .03) but was similar at 30 days (1.9% vs 1.5%; P = .44). There was no difference in the 8- to 24-hour CK-MB area under the curve between the MC-1 and placebo groups (median, 270 [interquartile range, 175-492] vs 268 [interquartile range, 170-456] hours x ng/mL; P = .11).

Conclusion In this population of intermediate- to high-risk patients undergoing CABG surgery, MC-1 did not reduce the composite of cardiovascular death or nonfatal MI.

Trial Registration clinicaltrials.gov Identifier: NCT00402506

Published online April 1, 2008 (doi:10.1001/jama.299.15.joc80027).

More...